339 related articles for article (PubMed ID: 12219785)
1. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
3. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
6. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
8. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Kowalski PJ; Rubin MA; Kleer CG
Breast Cancer Res; 2003; 5(6):R217-22. PubMed ID: 14580257
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
11. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
12. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
[TBL] [Abstract][Full Text] [Related]
13. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
[TBL] [Abstract][Full Text] [Related]
14. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
15. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
16. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
18. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
[TBL] [Abstract][Full Text] [Related]
19. [Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer].
García Tamayo J; Blasco Olaetxea E; Morales A; Molina J; Guzmán Bistoni C; Méndez V
Invest Clin; 2006 Dec; 47(4):371-83. PubMed ID: 17176905
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
